Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00001292 · ClinicalTrials.gov registry record

Study of Scaling Disorders and Other Inherited Skin Diseases

A clinical trial of Lamellar Ichthyosis and Genetic Skin Disease, sponsored by National Cancer Institute (NCI).

Completed
Registry status
1
Study location

NCT00001292: Completed study of Lamellar Ichthyosis and Genetic Skin Disease, sponsored by National Cancer Institute (NCI).

NCT00001292 is a study of Lamellar Ichthyosis and Genetic Skin Disease that has completed, run by National Cancer Institute (NCI). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00001292, a study of Lamellar Ichthyosis and Genetic Skin Disease, has completed, sponsored by National Cancer Institute (NCI).

COMPLETED
Registry status
1
Study location

Study Summary

The purpose of this study is to identify the genes responsible for certain scaling disorders and other inherited skin diseases and to learn about the medical problems they cause. In some cases, these may include problems affecting organs other than the skin, such as the eyes, teeth and bones. Patients with inherited skin disorders, including Darier's disease (keratosis follicularis), lamellar ichthyosis, epidermolysis bullosa, cystic acne, and others, and their relatives may be eligible for this study. Patients will have a medical history, physical examination with particular emphasis on the skin, and routine blood tests. Additional procedures for patients and unaffected relatives may include: 1. Blood sample collection 2. Dental exam with X-ray of the jaw 3. Eye examination 4. X-rays of the skull, ribs, chest, hands, feet, spine, arms, or legs 5. Bone density scan 6. Photographs of the skin 7. Skin biopsies (removal of a small tissue sample under local anesthetic) 8. Buccal sample (gentle brushing inside the cheek to collect a cell sample) for gene studies Patients who request the results of their gene testing will be provided this information.

Study Locations (1)

Maryland

  • National Cancer Institute (NCI) - Bethesda

Trial Details

FieldValue
Start Date 1992-02
Est. Completion 2001-04
National Cancer Institute (NCI)

3,257 total trials

What the finished NCT00001292 record still lists

NCT00001292 is an observational study that tracks outcomes without assigning an intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.

The record links to 3 conditions, with Lamellar Ichthyosis appearing as the primary indexed condition, and to 0 interventions.

NCT00001292 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT00001292 about?

NCT00001292 is a clinical study titled "Study of Scaling Disorders and Other Inherited Skin Diseases". The purpose of this study is to identify the genes responsible for certain scaling disorders and other inherited skin diseases and to learn about the medical problems they cause. In some cases, these may include problems affecting organs other than the skin, such as the eyes, teeth and bones. Patie...

What is the current status of trial NCT00001292?

This trial is currently completed. The study started on 1992-02. Estimated completion is 2001-04.

What conditions does trial NCT00001292 study?

This clinical trial studies the following conditions: Lamellar Ichthyosis, Genetic Skin Disease, Keratosis Follicularis.

Who is sponsoring clinical trial NCT00001292?

This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00001292 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Lamellar Ichthyosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00001292, the US trial registry maintained by the National Library of Medicine. NCT00001292 (unsized enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.